Ignite Creation Date:
2025-12-24 @ 11:57 PM
Ignite Modification Date:
2025-12-25 @ 9:54 PM
Study NCT ID:
NCT03576651
Status:
COMPLETED
Last Update Posted:
2020-01-07
First Post:
2018-06-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study to Compare the Pharmacokinetics of JHL1149 and Bevacizumab (Avastin) in Healthy Male Volunteers
Sponsor:
JHL Biotech, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-24
Start Date Type:
ACTUAL
Primary Completion Date:
2018-09-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-12-13
Completion Date Type:
ACTUAL
First Submit Date:
2018-06-25
First Submit QC Date:
None
Study First Post Date:
2018-07-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-01-05
Last Update Post Date:
2020-01-07
Last Update Post Date Type:
ACTUAL